Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Medy-Tox Inc. (086900)
Market Open
11 Aug, 06:30
KRX SM
All
(1)
KR
(1)
KRX SM
Primary
₩
77,900.
00
-3,000
-3.7083%
₩
673.66B
Market Cap
-
P/E Ratio
3,809.52%
Div Yield
11,103
Volume
-
Eps
₩
80,900
Previous Close
Watching
Watch
Add Transaction
Day Range
75,400
79,800
Year Range
66,000
144,700
Want to track
086900
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Medy-Tox Inc. (086900) Statistics
Valuation metrics
Market Cap
673.66B
Enterprise value
602.94B
Trailing P/E (ttm)
24.95
Forward P/E
17.73
PEG ratio
-14.53
Price/Sales (ttm)
2.13
Price/Book (mrq)
1.57
Enterprise Value/Revenue
2.47
Enterprise Value/EBITDA
15.71
Overview
Shares outstanding
6.58M
Float
5.12M
Shares short
-
% Held by insiders
0.21%
% Held by institutions
0.12%
Average volume (10 days)
22.96K
Average volume (90 days)
50.9K
Price summary
52-Week low
66,000
52-Week high
144,700
Beta
0.47
50-Day moving average
74,642.86
200-Day moving average
100,436.3
Dividends and splits
Forward annual dividend rate
3,809.52
Forward annual dividend yield
0.0372%
Trailing annual dividend rate
1,200
Trailing annual dividend yield
0.015%
5-Year annual dividend yield
0.41%
Payout ratio
0.43
Dividend Date
-
Ex-Dividend Date
-
Last split factor
1:1
Last split Date
28 Dec 2022
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.08%
Operating margin
0.08%
Operational effectiveness
Return on assets
0.04%
Return on equity
0.05%
Income Statement
Revenue (ttm)
247.29B
Revenue per share (ttm)
33,083.15
Quarterly revenue growth (yoy)
0.1%
Gross profit (ttm)
142.84B
EBITDA
30.95B
Net income to common (ttm)
15.62B
Diluted EPS (ttm)
2,790.84
Quarterly earnings growth (yoy)
-0.05%
Balance Sheet
Total cash (mrq)
48.94B
Total cash per share (mrq)
5,766.4
Total debt (mrq)
76.63B
Total Debt/Equity (mrq)
0.33
Current ratio (mrq)
1.01%
Book value per share (mrq)
51,478.47
Cash Flow
Cash flow statement
61.41B
Levered free cash flow (LFCF)
12.48B